Moreover, activated BRAF usually drives melanocytic proliferation but seems to be insufficient to promote melanoma growth and progression, unless alterations in additional cell-cycle regulating factors – such as p53 impairment, p16CDKN2A loss, increased levels of active AKT – coexist (2, 12). The gene discussed is BRAF; the disease is melanoma.